Keywords: اینترلوکین 33; Aneurysm; Subarachnoid hemorrhage; Interleukin-33; Inflammation; Prognosis; `aSAH; aneurysmal subarachnoid hemorrhage; WFNS; World Federation of Neurological Surgeons; IL-33; interleukin-33;
مقالات ISI اینترلوکین 33 (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: اینترلوکین 33; ATG; autophagy-related proteins; CMA; chaperone-mediated autophagy; ULK1; Unc-51-like kinase 1; PI3K; phosphatidylinositol 3-kinase; mTOR; mammalian target of rapamycin; PE; phosphatidylethanolamine; IFN-γ; interferon-γ; IL-1; interleukin-1; IL-17; inte
Keywords: اینترلوکین 33; BBB; blood-brain barrier; CNS; central nervous system; CSF; cerebrospinal fluid; DCs; dendritic cells; EAE; experimental autoimmune encephalomyelitis; GFAP; glial fibrillary acidic protein; IFN; interferon; IL; interleukin; IVIG; intravenous immunoglobuli
Keywords: اینترلوکین 33; Interleukin-33; Acute asthma; Exacerbation; Type 2 cytokines; Adults; ACQ; asthma control questionnaire; COPD; chronic obstructive pulmonary disease; DD PCR; droplet digital polychain reaction; ED; emergency department; FeNO; fractional exhaled nitric oxi
Keywords: اینترلوکین 33; Tumor biophysics; Cancer; Metastasis; ECM stiffness; Growth factors; Activin/TGFβ; ECM; Extracellular matrix; CAF; Cancer associated fibroblast; LOX; Lysyl Oxidase; IGFs; Insulin-like growth factors; EGF; Epidermal growth factor; TGFβ; Transforming grow
Keywords: اینترلوکین 33; Asthma; Children; Interleukin-33; Meta-analysis;
Keywords: اینترلوکین 33; (TGF-β); transforming growth factor-beta; (VEGF); vascular endothelial growth factor; (TNF-α); tumor necrosis factor-alpha; (HGF); hepatocyte growth factor; (IL-1α); interleukin-1alpha; (IL1-β); interleukin-1beta; (IL-6); interleukin-6; (IL-33); inter
Keywords: اینترلوکین 33; Cytokines; IL-1 family; Placenta; Reproductive immunology; IL-1α; interleukin-1alpha; IL-1β; interleukin-1beta; IL-18; interleukin-18; IL-33; interleukin-33; IL-37; interleukin-37; IL-1Ra; IL-1 receptor agonist; IL-18BP; IL-18 binding-protein; IL-36Ra;
Keywords: اینترلوکین 33; NF-κB; nuclear factor kappa-light chain enhancement of activated B cell; NLR; (Nod)-like receptor; NLRP 3; (Nod)-like receptor pyrin domain containing 3 inflammasome; IL-1α; interleukin-1-alpha; IL-1β; interleukin-1-beta; IL-4; interleukin-4; IL-6; int
Keywords: اینترلوکین 33; AS; Angeli's salt; AST; aspartate aminotransferase; ALT; alanine transaminase; BALF; bronchoalveolar lavage fluid; CGRP; calcitonin gene-related peptide; COX-2; cyclooxygenase-2; CFU; colony-forming unity; cGMP; cyclic guanosine monophosphate; PKG; cGMP-d
Keywords: اینترلوکین 33; AC; adenocarcinomas; AdIL-32; adenoviral overexpression of IL-32; AICD; activation-induced cell death; BAVECs; bovine aortic vascular endothelial cells; BLP; bacterial lipoprotein; CML; chronic myeloid leukemia; Con A; concanavalin A; COPD; chronic obstru
Keywords: اینترلوکین 33; Interleukin-33; Renal fibrosis; Tubular cell injury; Obstructive nephropathy;
Keywords: اینترلوکین 33; Sepsis; T lymphocyte; Apoptosis; Interleukin-33
Keywords: اینترلوکین 33; Fibroblast-like synoviocytes; Interleukin-33; Osteoclastogenesis; Rheumatoid arthritis; Transcriptional repressor;
Keywords: اینترلوکین 33; Interleukin-33; ST2; Tongue squamous cell carcinoma; Inflammation; Mast cell; Malignant potential;
Keywords: اینترلوکین 33; Interleukin-33; Restenosis; Coronary artery disease; Myocardial infarction; Percutaneous coronary intervention;
Keywords: اینترلوکین 33; Interleukin-33; Sarcoidosis; Granuloma; Macrophage; Biomarker; Immunohistochemistry
Keywords: اینترلوکین 33; Interleukin-33; Gamma-glutamyl transferase; Biliary atresia;
Keywords: اینترلوکین 33; DTAF; dichlorotriazinylaminofluorescein; DAPI; 4â²,6-diamidino-2-phenylindole; EGFP; enhanced green fluorescent protein; EYFP; enhanced yellow fluorescent protein; FSC; forward scatter; HMGB1 protein; high mobility group box 1 protein; IL; interleukin; L
Keywords: اینترلوکین 33; APC; antigen presenting cell; BAL; bronchoalveolar lavage; CBM; chromatin-binding motiff; CAV; chronic allograft vasculopathy; DC; dendritic cells; DC-SIGN; DC-specific intercellular adhesion molecule-3-grabbing non-integrin; DSA; donor specific antibodie
Keywords: اینترلوکین 33; IL-25, interleukin-25; IL-33, interleukin-33; TSLPR, thymic stromal lymphoprotein receptorInterleukin-25; Interleukin-33; Thymic stromal lymphoprotein; Malaria; Mouse
IL-33 stimulates expression of the GPR84 (EX33) fatty acid receptor gene and of cytokine and chemokine genes in human adipocytes
Keywords: اینترلوکین 33; Adipocyte; Adipose tissue; GPR84; Inflammation; Interleukin-33;
The association of IL-33 and Foxp3 gene polymorphisms with recurrent pregnancy loss in Egyptian women
Keywords: اینترلوکین 33; Recurrent pregnancy loss; Interleukin-33; Foxp3, Polymorphism; PCR;
Evaluation of the sST2-guided optimization of medical treatments of patients admitted for heart failure, to prevent readmission: Study protocol for a randomized controlled trial
Keywords: اینترلوکین 33; HF; heart failure; ACE-inhibitor; angiotensin converting enzyme inhibitor; ARBs; angiotensin receptor blockers; LVEF; left ventricular ejection fraction; AHA/ACC; American College of Cardiology/American Heart Association; ESC; European Society of Cardiolo
Tranilast inhibits interleukin-33 production by macrophages
Keywords: اینترلوکین 33; Tranilast (PubChem CID: 5282230); LY294002 (PubChem CID: 3973); Tranilast; Interleukin-33; Macrophages; Lipopolysaccharide; Phosphoinositide-3-kinase;
IL-33 gene variants and protein expression in pediatric Tunisian asthmatic patients
Keywords: اینترلوکین 33; Interleukin-33; Childhood asthma; Inflammatory cytokines; Polymorphisms; Case-control study;
Extracts of Cordyceps sinensis inhibit breast cancer cell metastasis via down-regulation of metastasis-related cytokines expression
Keywords: اینترلوکین 33; WECS; water extracts of Cordyceps sinensis; MMP-9; matrix metalloproteinase-9; CCK8; cell counting kit-8; ELISA; enzyme-linked immunosorbent assay; CCL17; CC chemokine ligand 17; OPN; osteopontin; IL-33; interleukin-33; CCL12; CC chemokine ligand 12; CCL6
Elimination of eosinophils using anti-IL-5 receptor alpha antibodies effectively suppresses IL-33-mediated pulmonary arterial hypertrophy
Keywords: اینترلوکین 33; ADCC; antibody dependent cell-mediated cytotoxicity; IL; IL-5; IL-5Rα; IL-5 receptor α chain; ILC2; group 2 innate lymphoid cell; Th2; T helper type 2; PAH; pulmonary arterial hypertension; CDR; complementary determining region; SMA; smooth muscle actin
Interleukin-33 levels are elevated in chronic allograft dysfunction of kidney transplant recipients and promotes epithelial to mesenchymal transition of human kidney (HK-2) cells
Keywords: اینترلوکین 33; CAD; chronic allograft dysfunction; EMT; epithelial to mesenchymal transition; IL-33; Interleukin-33; KTRs; kidney transplantation recipients; MAPK; mitogen-activated protein kinase; Interleukin-33; Kidney transplantation; Fibrosis; Chronic allograft dysf
Evaluation of biomaterial scaffold delivery of IL-33 as a localized immunomodulatory agent to support cell transplantation in adipose tissue
Keywords: اینترلوکین 33; Immunomodulation; Interleukin-33; Transplantation; Biomaterials;
The IL-33/ST2 pathway, inflammation and atherosclerosis: Trigger and target?
Keywords: اینترلوکین 33; ACS; acute coronary syndrome; CAD; coronary artery disease; CANTOS; Canakinumab Antiinflammatory Thrombosis Outcome Study; HF; heart failure; IL; Interleukin; IL-1RAcP; IL-1R accessory protein; MI; myocardial infarction; ST; suppression of tumorigenesis (
IL-33/ST2 Pathway as a Rational Therapeutic Target for CNS Diseases
Keywords: اینترلوکین 33; AD; Alzheimer's disease; ALS; amyotrophic lateral sclerosis; CCI; chronic constriction injury; CNS; central nervous system; EAE; experimental autoimmune encephalomyelitis; ECM; experimental cerebral malaria; ICH; intracerebral hemorrhage; IL-1RAcp; IL-1
Clock-dependent temporal regulation of IL-33/ST2-mediated mast cell response
Keywords: اینترلوکین 33; CLOCK; Cytokine; IL-33; Mast cells; ST2; IL-33; interleukin-33; BMMCs; bone marrow-derived mast cells; BM basophils; bone marrow-derived basophils; ILC2s; group-2 innate lymphoid cells; SCN; suprachiasmatic nucleus; Per; Period; Cry; Cryptochrome; ZT; Zei
Serum soluble ST2 is a promising prognostic biomarker in HBV-related acute-on-chronic liver failure
Keywords: اینترلوکین 33; biomarker; HBV-related acute-on-chronic liver failure; interleukin-33; prognosis; soluble ST2;
Effects of obesity on IL-33/ST2 system in heart, adipose tissue and liver: study in the experimental model of Zucker rats
Keywords: اینترلوکین 33; Suppression of tumorigenicity 2; Interleukin-33; Obesity; Inflammation;
Interleukin-33 attenuates doxorubicin-induced cardiomyocyte apoptosis through suppression of ASK1/JNK signaling pathway
Keywords: اینترلوکین 33; Doxorubicin; Apoptosis; ASK1; JNK; Interleukin-33;
Anti-ST2 monoclonal antibody inhibits eosinophil infiltration in Angiostrongylus cantonensis-infected mice
Keywords: اینترلوکین 33; Angiostrongylus cantonensis; Interleukin-33; ST2
Lentivirus expressing soluble ST2 alleviates bleomycin-induced pulmonary fibrosis in mice
Keywords: اینترلوکین 33; Interleukin-33; ST2; Lentivirus vector; Inflammation; Collagen; Pulmonary fibrosis
Interleukin-33 facilitates neutrophil recruitment and bacterial clearance in S. aureus-caused peritonitis
Keywords: اینترلوکین 33; Interleukin-33; Peritonitis; Neutrophils; Phagocytosis; Reactive oxygen species
HMGB1 regulates IL-33 expression in acute respiratory distress syndrome
Keywords: اینترلوکین 33; ARDS; acute respiratory distress syndrome; IL-33; interleukin-33; HMGB1; high mobility group protein-1; LPS; lipopolysaccharide; TLR4; toll-like receptor 4; rHMGB1; recombinant HMGB1; RAGE; the receptor for advanced glycation end-product; BALF; bronchoalv
Inflammation elevated IL-33 originating from the lung mediates inflammation in acute lung injury
Keywords: اینترلوکین 33; ARDS; acute respiratory distress syndrome; ELISA; enzyme-linked immunosorbent assay; ICU; intensive care unit; PBS; phosphate buffered saline; H2O2; hydrogen peroxide; VFDs; ventilator-free days; RA; rheumatoid arthritis; AD; atopic dermatitis; IL-33; int
Construction and expression of human scFv-Fc against interleukin-33
Keywords: اینترلوکین 33; IL-33; interleukin-33; DCs; dendritic cells; scFv; single-chain Fv fragment; PBMC; peripheral blood mononuclear cells; SP; signal peptide; ECL; chemiluminescence; Eukaryotic expression vector; Human scFv-Fc; Human IL-33;
Circulating IL-33 level is associated with the progression of lung cancer
Keywords: اینترلوکین 33; Interleukin-33; Lung cancer; Surgery; Chemotherapy; Stage; Plasma;
Analytical and clinical evaluation of a rapid quantitative lateral flow immunoassay for measurement of soluble ST2 in human plasma
Keywords: اینترلوکین 33; Heart failure; Dyspnea, sST2; POCT; Interleukin-33;
Soluble ST2 reflects hemodynamic stress in non-ischemic heart failure
Keywords: اینترلوکین 33; ST2; suppressor of tumorigenicity 2; sST2; soluble ST2; IL-33; Interleukin-33; ECG; electrocardiogram; NT-proBNP; N-terminal pro-B-type natriuretic peptide; NYHA; New York Heart Association; Dilated cardiomyopathy; ST2; Hemodynamics; Etiology; Prognosis;
Single high-dose irradiation aggravates eosinophil-mediated fibrosis through IL-33 secreted from impaired vessels in the skin compared to fractionated irradiation
Keywords: اینترلوکین 33; Radiotherapy; Skin injury; Eosinophil-mediated fibrosis; Interleukin-33;
Production of interleukin (IL)-33 in the lungs during multiple antigen challenge-induced airway inflammation in mice, and its modulation by a glucocorticoid
Keywords: اینترلوکین 33; Interleukin-33; Asthma; M2 macrophages; Dendritic cells; Epithelial cells; Glucocorticoid
Soluble ST2 in heart failure
Keywords: اینترلوکین 33; Heart failure; Diagnosis; Prognosis; Interleukin-33; Dyspnea; Inflammation; Monitoring; Biomarker-guided therapy;
Serum levels of Interleukin-33 and its soluble receptor ST2 in asthmatic patients
Keywords: اینترلوکین 33; Interleukin-33; Soluble ST2; Bronchial asthma
Interleukin-33/ST2 signaling promotes production of interleukin-6 and interleukin-8 in systemic inflammation in cigarette smoke-induced chronic obstructive pulmonary disease mice
Keywords: اینترلوکین 33; Interleukin-33; Peripheral blood mononuclear cells; Chronic obstructive pulmonary disease; Mouse models;